A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy. Personalized immunotherapies are an emerging treatment approach that directs the patient’s immune response to target their unique cancer. To design...
Researchers say the study’s findings could provide insight into the discrepancies in cancer outcomes between men and women. For years, it has been known that mortality rates for men are higher for many types...
Study finds high consumption of ultraprocessed foods may be linked to increased risk of both all-cause and cancer-specific death. Ultraprocessed foods are often low in essential nutrients such as vitamins, minerals, and fiber, and...
The four-biomarker blood panel enhanced the detection of pancreatic cancer compared to standard testing. The pancreas aids with digestion and produces hormones, such as insulin and glucagon, that help regulate blood sugar levels. When...
ctDNA status may also inform treatment plan. Breast cancer is the most common form of non-skin cancer in the United States, and human epidermal growth factor receptor 2-positive breast cancer, or HER2-positive breast cancer,...
De-escalating treatment for patients with chronic cancers can be beneficial for overall mental health. Patients with chronic lymphocytic leukemia (CLL) are typically treated with Bruton’s tyrosine kinase inhibitors, or BTKis. Although effective, patients typically...
Patients with cancer in rural or high-poverty areas were associated with the most significant improvements in five-year survival. In 2014, a provision under the Patient Protection and Affordable Care Act (ACA) took effect, allowing...
Cancer survivors profiled over the past 15 years in the AACR Cancer Progress Reports shared updates on their lives and the progress made against cancer.
The second AACR Childhood Cancer Predisposition Workshop gathered experts from around the world to refine surveillance strategies, expanding recommendations to nearly 100 syndromes.
Study found teclistamab-cqyv, an immunotherapy, led to responses in patients with high-risk, heavily pretreated multiple myeloma, including after prior BCMA therapy. Teclistamab-cqyv (Tecvayli), a type of immunotherapy, received accelerated approval from the U.S. Food...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More